Wolfe Research raises Hexcel stock price target on strong earnings

Hexcel reported Q1 2026 EPS of $0.59, beating the $0.43 consensus by 37.21%, and revenue of $502 million versus $485.83 million expected. Wolfe Research raised its price target to $101 from $92 while keeping an Outperform rating, citing a strong earnings beat and improving aircraft production trends. Shares rose 5% on the day and are up 84% over the past year, though the stock is noted as expensive at 63.6x earnings.

Analysis

HXL is acting like a classic aerospace beta rerating, but the more important signal is that the market is starting to trust the durability of the production upcycle rather than just the next quarter print. If OEM rates continue to stair-step higher, Hexcel should see mix and volume benefits flow with a lag, which means the equity can keep working even without another guidance raise. That creates a path for multiple expansion if investors conclude the current multiple is being underwritten by a longer backlog monetization cycle rather than a one-off beat.

The second-order read-through is more interesting across the supply chain: composites and structurals are likely to outperform other aerospace inputs as de-stocking fades and airframe build rates normalize. That favors higher-quality, capital-light suppliers with pricing discipline, while lower-tier suppliers still trapped in working-capital rebuild may lag despite the same end-market tailwind. The market is also implicitly saying jet fuel sensitivity is losing relevance for this part of the chain, which reduces the usual macro bear case and makes the stock more dependent on production cadence than airline demand.

The main risk is that the current move has outrun near-term fundamentals and is vulnerable to any hesitation in OEM execution, especially on the A350 where inventory normalization still matters. Over the next 1-2 quarters, a single miss on build-rate assumptions could compress the multiple quickly because the stock is already pricing in a lot of good news. Over a 6-12 month horizon, the more durable risk is that the rally becomes crowded and valuation starts to dominate once the market stops rewarding incremental evidence of recovery.

Consensus may be underestimating how much of the upside is already in the shares, but also underestimating how long the rerating can persist if the supply chain keeps healing. In other words, this is less about whether aerospace is good and more about whether the market can stay patient through a multi-quarter normalization story. If production data remains constructive, Hexcel can stay a momentum name; if not, it becomes a valuation problem fast.

Key Decisions for Investors

• Stay long HXL for 1-3 months, but treat it as a momentum/earnings follow-through trade rather than a fundamental compounder at current levels; upside remains if OEM build rates keep improving, but stop-loss discipline matters because the stock is already expensive.
• Buy HXL calls or use a call spread into the next production/read-through catalysts over the next 4-8 weeks; structure for convexity since the stock can rerate further on any positive aerospace supply-chain data, but cap premium risk given stretched valuation.
• Pair long HXL vs short a more economically sensitive industrial or materials name over 1-2 quarters; thesis is that aerospace production normalization is idiosyncratically stronger and less tied to near-term macro than broader industrial demand.
• For more valuation-sensitive accounts, fade strength with a tactical short or put spread only if the stock extends another 10-15% without a corresponding raise in guidance; the risk/reward improves once the multiple detaches further from fundamentals.
• Watch for any OEM or inventory commentary over the next earnings cycle; if A350 destocking worsens or production cadence slips, reduce exposure immediately because the downside would likely come from multiple compression rather than EPS reset.